Cargando…

Pharmacological characterisation of novel adenosine A(3) receptor antagonists

The adenosine A(3) receptor (A(3)R) belongs to a family of four adenosine receptor (AR) subtypes which all play distinct roles throughout the body. A(3)R antagonists have been described as potential treatments for numerous diseases including asthma. Given the similarity between (adenosine receptors)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barkan, Kerry, Lagarias, Panagiotis, Stampelou, Margarita, Stamatis, Dimitrios, Hoare, Sam, Safitri, Dewi, Klotz, Karl-Norbert, Vrontaki, Eleni, Kolocouris, Antonios, Ladds, Graham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695835/ https://www.ncbi.nlm.nih.gov/pubmed/33247159 http://dx.doi.org/10.1038/s41598-020-74521-y

Ejemplares similares

Discovery of a High Affinity Adenosine A(1)/A(3) Receptor Antagonist with a Novel 7-Amino-pyrazolo[3,4-d]pyridazine Scaffold
por: Suchankova, Anna, et al.
Publicado: (2022)

Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020)

Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020)

Molecular Biophysics of Class A G Protein Coupled Receptors–Lipids Interactome at a Glance—Highlights from the A(2A) Adenosine Receptor
por: Tzortzini, Efpraxia, et al.
Publicado: (2023)

Discovery and Structure–Activity Relationship Studies of Novel Adenosine A(1) Receptor-Selective Agonists
por: Preti, Barbara, et al.
Publicado: (2022)

Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes
por: Bolcato, Chiara, et al.
Publicado: (2007)

Selective activation of Gαob by an adenosine A(1) receptor agonist elicits analgesia without cardiorespiratory depression
por: Wall, Mark J., et al.
Publicado: (2022)

Suppression of Proliferation of Human Glioblastoma Cells by Combined Phosphodiesterase and Multidrug Resistance-Associated Protein 1 Inhibition
por: Kopanitsa, Liliya, et al.
Publicado: (2021)

A(2A) Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?
por: Spinaci, Andrea, et al.
Publicado: (2022)

New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile
por: Lambertucci, Catia, et al.
Publicado: (2007)

Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure–activity profile
por: Cacciari, Barbara, et al.
Publicado: (2006)

Structure‐based identification of dual ligands at the A(2A)R and PDE10A with anti‐proliferative effects in lung cancer cell‐lines
por: Kalash, Leen, et al.
Publicado: (2021)

Hyperglycaemia does not affect antigen-specific activation and cytolytic killing by CD8(+) T cells in vivo
por: Recino, Asha, et al.
Publicado: (2017)

Effect of Adenosine Receptor Antagonists on Adenosine-Pretreated PC12 Cells Exposed to Paraquat
por: Shang, Liangcheng, et al.
Publicado: (2022)

In Silico Identification and Evaluation of Natural Products as Potential Tumor Necrosis Factor Function Inhibitors Using Advanced Enalos Asclepios KNIME Nodes
por: Papadopoulou, Dimitra, et al.
Publicado: (2021)

Irreversible Antagonists for the Adenosine A(2B) Receptor †
por: Temirak, Ahmed, et al.
Publicado: (2022)

Correction to: Conformational energies of reference organic molecules: benchmarking of common efficient computational methods against coupled cluster theory
por: Stylianakis, Ioannis, et al.
Publicado: (2023)

Conformational energies of reference organic molecules: benchmarking of common efficient computational methods against coupled cluster theory
por: Stylianakis, Ioannis, et al.
Publicado: (2023)

Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against M(pro) and cathepsin L
por: Sacco, Michael Dominic, et al.
Publicado: (2020)

Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M(pro) and cathepsin L
por: Sacco, Michael Dominic, et al.
Publicado: (2020)

Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
por: Yang, Zijian, et al.
Publicado: (2015)

A covalent antagonist for the human adenosine A(2A) receptor
por: Yang, Xue, et al.
Publicado: (2016)

Tumor Immunotherapy Using A(2A) Adenosine Receptor Antagonists
por: Zhang, Jinfeng, et al.
Publicado: (2020)

A(3) Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
por: Spinaci, Andrea, et al.
Publicado: (2022)

A(2B) adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
por: Tay, Apple Hui Min, et al.
Publicado: (2022)

The A(2B) adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1
por: Koussémou, Marthe, et al.
Publicado: (2018)

Adenosine-guided radiofrequency catheter ablation of atrial fibrillation: A meta-analysis of randomized control trials
por: Letsas, Konstantinos P., et al.
Publicado: (2017)

Study of SQ109 analogs binding to mycobacterium MmpL3 transporter using MD simulations and alchemical relative binding free energy calculations
por: Stampolaki, Marianna, et al.
Publicado: (2023)

Effect of Adenosine and Adenosine Receptor Antagonists on Retinal Müller Cell Inwardly Rectifying Potassium Channels under Exogenous Glutamate Stimulation
por: Lin, Zhongjing, et al.
Publicado: (2018)

Adenosine Receptor Ligands: Coumarin–Chalcone Hybrids as Modulating Agents on the Activity of hARs
por: Vazquez-Rodriguez, Saleta, et al.
Publicado: (2020)

Identification of Novel Adenosine A(2A) Receptor Antagonists by Virtual Screening
por: Langmead, Christopher J., et al.
Publicado: (2012)

Striatal Pre- and Postsynaptic Profile of Adenosine A(2A) Receptor Antagonists
por: Orru, Marco, et al.
Publicado: (2011)

The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?
por: Marzagalli, Rubina, et al.
Publicado: (2015)

Pyrazolo Derivatives as Potent Adenosine Receptor Antagonists: An Overview on the Structure-Activity Relationships
por: Cheong, Siew Lee, et al.
Publicado: (2011)

The Adenosine Receptor Antagonist, 7-Methylxanthine, Alters Emmetropizing Responses in Infant Macaques
por: Hung, Li-Fang, et al.
Publicado: (2018)

Free-Energy Calculations for Bioisosteric Modifications of A(3) Adenosine Receptor Antagonists
por: Jandova, Zuzana, et al.
Publicado: (2019)

Computational studies of the binding modes of A(2A) adenosine receptor antagonists
por: Ye, Y., et al.
Publicado: (2007)

Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy
por: Franco, Rafael, et al.
Publicado: (2021)

A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway
por: Wurm, Melanie, et al.
Publicado: (2021)

Identification of distinct SET/TAF-Iβ domains required for core histone binding and quantitative characterisation of the interaction
por: Karetsou, Zoe, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_5pn9kkvndqq652ocp7s39tuvkt